Menu Search
Equities

Sipai Health Technology Co, Ltd

314:HKG.HZ

Sipai Health Technology Co, Ltd

Actions
  • Price (HKD)5.24
  • Today's Change0.01 / 0.19%
  • Shares traded696.54k
  • 1 Year change-30.41%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Sipai Health Technology Co, Ltd grew revenues 14.39% from 4.12bn to 4.71bn while net income improved from a loss of 1.37bn to a smaller loss of 255.77m.
Gross margin9.18%
Net profit margin-5.05%
Operating margin-4.97%
Return on assets-7.98%
Return on equity-14.62%
Return on investment-13.82%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Sipai Health Technology Co, Ltd fell by 960.03m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 133.50m for operations while cash used for investing totalled 720.81m.
Cash flow per share-0.2606
Price/Cash flow per share--
Book value per share2.11
Tangible book value per share1.98
More ▼

Balance sheet in CNYView more

Sipai Health Technology Co, Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 3.86%.
Current ratio1.82
Quick ratio1.58
Total debt/total equity0.0405
Total debt/total capital0.0386
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.